IBANDRONATE SODIUM
NDC 62756-218, IBANDRONATE SODIUM, injection, solution, from Sun Pharmaceutical Industries, Inc..
- Product NDC
- 62756-218
- Status
- Listed
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA090853
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62756-218 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- IBANDRONATE SODIUM3 mg/3mL
Pharmacologic classes
Bisphosphonate [EPC]; Diphosphonates [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62756-218-40 | 62756021840 | 1 VIAL, SINGLE-DOSE in 1 CARTON (62756-218-40) / 3 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/be514be6-727a-4d6c-993b-52144f8e6de8
Use it
Look up 62756-218 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62756-218 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62756-218. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.